Gilead Sciences (GILD) Return on Assets (2009 - 2026)
Gilead Sciences' (GILD) quarterly Return on Assets came in at 0.0% in Q1 2026, little changed YoY from 0.0% in Q1 2025, and up 10.08% on a QoQ basis from 0.0% in Q4 2025.
Gilead Sciences (GILD) Return on Assets (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 18 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Assets climbed to 0.0% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2026 to a low of 0.0% in Q3 2024.
- A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
- The widest YoY moves for Return on Assets: up 0 bps in 2022, down 0 bps in 2022.
- Tracing GILD's Return on Assets over 5 years: stood at 0.0% in 2022, then climbed by 24 bps to 0.0% in 2023, then slumped by 91 bps to 0.0% in 2024, then jumped by 1685 bps to 0.0% in 2025, then gained by 10 bps to 0.0% in 2026.
- The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 0.00% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 0.00% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 0.00% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 0.00% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 0.00% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 0.00% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 0.00% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.00% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |